Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)

The Journal of Antimicrobial Chemotherapy
Jon Salmanton-GarcíaFungiScope® ECMM/ISHAM Working Group

Abstract

First-line antifungal treatment for invasive mucormycosis (IM) consists of liposomal amphotericin B. Salvage treatment options are limited and often based on posaconazole oral suspension. With the approval of posaconazole new formulations, patients could benefit from improved pharmacokinetics, safety and tolerability. Our aim was to assess the effectiveness of posaconazole new formulations for IM treatment. We performed a case-matched analysis with proven or probable IM patients from the FungiScope® Registry. First-line posaconazole new formulations (1st-POSnew) and first-line amphotericin B plus posaconazole new formulations (1st-AMB+POSnew) cases were matched with first-line amphotericin B-based (1st-AMB) treatment controls. Salvage posaconazole new formulations (SAL-POSnew) cases were matched with salvage posaconazole oral suspension (SAL-POSsusp) controls. Each case was matched with up to three controls (based on severity, haematological/oncological malignancy, surgery and/or renal dysfunction). Five patients receiving 1st-POSnew, 18 receiving 1st-AMB+POSnew and 22 receiving SAL-POSnew were identified. By day 42, a favourable response was reported for 80.0% (n = 4/5) of patients receiving 1st-POSnew, for 27.8% (n = 5/18) re...Continue Reading

References

Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maureen M RodenThomas J Walsh
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikDimitrios P Kontoyiannis
Apr 25, 2007·Antimicrobial Agents and Chemotherapy·Nikolaos G AlmyroudisShimon Kusne
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios ChamilosDimitrios P Kontoyiannis
Jul 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brahm H SegalBen E De Pauw
May 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergAshraf S Ibrahim
Sep 17, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A Alastruey-IzquierdoJ L Rodríguez-Tudela
Dec 17, 2009·The Journal of Antimicrobial Chemotherapy·M J G T RüpingO A Cornely
Mar 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P KontoyiannisPeter G Pappas
Oct 18, 2011·Emerging Infectious Diseases·Benjamin J ParkDimitrios P Kontoyiannis
Aug 25, 2012·Critical Reviews in Microbiology·Joerg J VehreschildOliver A Cornely
Feb 1, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O A CornelyG Petrikkos
Sep 1, 2015·The Journal of Antimicrobial Chemotherapy·F LanternierUNKNOWN French Mycosis Study Group
Nov 28, 2015·The Journal of Antimicrobial Chemotherapy·Oliver A CornelyHetty Waskin
Mar 13, 2016·The Lancet Infectious Diseases·Francisco M MartyUNKNOWN VITAL and FungiScope Mucormycosis Investigators
Nov 12, 2016·BMC Infectious Diseases·Zoi Dorothea PanaUNKNOWN Collaborators of Zygomyco.net and/or FungiScope™ Registries*
Jul 22, 2017·Mycoses·Danila Seidel FungiScope Group
Mar 14, 2019·Mycoses·Jesús FortunPilar Martín-Dávila

❮ Previous
Next ❯

Citations

Oct 30, 2019·Mycoses·Alexander F A D SchauwvliegheRoger J M Brüggemann
Jul 16, 2020·Expert Review of Hematology·Livio PaganoAlessandro Busca
Mar 24, 2020·Current Fungal Infection Reports·Victoria M StevensTyree H Kiser
Jul 16, 2020·Current Fungal Infection Reports·David R TribbleCarlos J Rodriguez
Apr 24, 2020·Drugs·Lu ChenRoger J M Brüggemann
Oct 13, 2020·Journal of the Pediatric Infectious Diseases Society·William J Steinbach
Jan 9, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Valliappan MuthuArunaloke Chakrabarti
Jan 28, 2021·Current Tropical Medicine Reports·Berenice Morales-FrancoClaudia Lisette Charles-Niño
Jul 29, 2020·Journal de mycologie médicale·K Brunet, B Rammaert
Aug 18, 2020·The Journal of Infection·Jon Salmanton-GarcíaUNKNOWN ECMM/ISHAM working group
Aug 6, 2021·Diagnostic Microbiology and Infectious Disease·Michael A PfallerMariana Castanheira
Aug 27, 2021·Therapeutic Advances in Infectious Disease·Mandeep Singh RahiIshmael A Jaiyesimi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
K K LimC J Burns-Cox
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M EricssonA Tärnvik
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
P VoitlA M Rokitansky
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Issam I RaadDimitrios P Kontoyiannis
© 2021 Meta ULC. All rights reserved